<?xml version="1.0" encoding="UTF-8"?>
<ref id="B65-plants-10-00667">
 <label>65.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Allam</surname>
    <given-names>R.M.</given-names>
   </name>
   <name>
    <surname>Al-Abd</surname>
    <given-names>A.M.</given-names>
   </name>
   <name>
    <surname>Khedr</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Sharaf</surname>
    <given-names>O.A.</given-names>
   </name>
   <name>
    <surname>Nofal</surname>
    <given-names>S.M.</given-names>
   </name>
   <name>
    <surname>Khalifa</surname>
    <given-names>A.E.</given-names>
   </name>
   <name>
    <surname>Mosli</surname>
    <given-names>H.A.</given-names>
   </name>
   <name>
    <surname>Abdel-Naim</surname>
    <given-names>A.B.</given-names>
   </name>
  </person-group>
  <article-title>Fingolimod interrupts the cross talk between estrogen metabolism and sphingolipid metabolism within prostate cancer cells</article-title>
  <source>Toxicol. Lett.</source>
  <year>2018</year>
  <volume>291</volume>
  <fpage>77</fpage>
  <lpage>85</lpage>
  <pub-id pub-id-type="doi">10.1016/j.toxlet.2018.04.008</pub-id>
  <pub-id pub-id-type="pmid">29654831</pub-id>
 </element-citation>
</ref>
